Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0G7MJ
|
||||
| Former ID |
DNC011318
|
||||
| Drug Name |
NSC-640556
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C<br />=CC5=CC=C(C=C5)[N+](=O)[O-]
|
||||
| InChI |
1S/C28H20N4O3S/c1-19-27(26(33)17-14-20-12-15-23(16-13-20)32(34)35)36-28(29-19)31-25(22-10-6-3-7-11-22)18-24(30-31)21-8-4-2-5-9-21/h2-18H,1H3/b17-14+
|
||||
| InChIKey |
IPRWXFAJXPKDLK-SAPNQHFASA-N
|
||||
| Target and Pathway | |||||
| Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.